期刊文献+

缺氧诱导因子在慢性肾脏疾病进展中的作用 被引量:1

原文传递
导出
摘要 全世界约10%的人群患有不同程度的慢性肾脏疾病(CKD),我国CKD的患病率也高达6.6%-13.8%。CKD的高发病率加上发展至终末期肾脏疾病(ESRD)和出现心脑血管疾病风险增加,使其成为威胁人类健康的重大疾病之一。缺氧诱导因子(HIF)是一种核转录因子,可以在缺氧的状态下调节多种基因的转录,参与对缺氧的适应性调节,近年来发现其在急性肾损伤(AKI)中具有肾保护作用而引起重视。但是HIF在CKD中的作用尚存在争议,本文将对HIF的特点、调节机制及其在CKD发生发展中的作用进行综述。
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2012年第9期740-743,共4页 Chinese Journal of Nephrology
  • 相关文献

参考文献44

  • 1Khwaja A, E1 Kossi M, Floege J, et al. The management of CKD: A look into the future. Kidney Int, 2007, 72: 1516- 1323.
  • 2Chen W, Wang H, Dong X, et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant, 2009, 24: 1205-1212.
  • 3Zhang L, Zhang P, Wang F, e t al. Prevalence and factors associated with CKD: A population study from Beijing. Am J Kidney Dis, 2008, 51: 373-384.
  • 4Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol, 1992, 12: 5447- 5454.
  • 5Makino Y, Kanopka A, Wilson WJ, et al. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J Biol Chem, 2002, 277: 32405-32408.
  • 6Gunaratnam L, Bonventre JV. HIF in kidney disease and development. J Am Soc Nephrol, 2009, 20: 1877-1887.
  • 7Kaelin WG Jr. The yon Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem Biophys Res Commun, 2005, 338: 627-638.
  • 8Semenza GL. Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med, 2010, 2: 336-361.
  • 9Kuschel A, Simon P, Tug S. Functional regulation of HIF-1 under normoxia-is there more than post-translational regulation? J Cell Physiol, 2012, 227: 514-524.
  • 10王德光,李学旺,李航,陈丽萌,段琳,李艳.胰岛素通过激活PI3K/mTOR通路诱导人肾小球系膜细胞血管内皮细胞生长因子转录[J].中国糖尿病杂志,2009,17(4):308-310. 被引量:3

二级参考文献31

  • 1李鹏,丁小强,曹长春,邹建洲,欧周罗.肾脏缺血预适应及细胞间黏附分子1的作用[J].中华肾脏病杂志,2004,20(3):199-201. 被引量:8
  • 2叶菡洋,袁伟杰,张志强,边琪,于建平,傅鹏,梅小斌,郭云珊,崔若兰.低蛋白加α酮酸饮食对5/6肾切除大鼠残肾组织炎症因子表达及病理变化的影响[J].中华肾脏病杂志,2007,23(6):394-399. 被引量:3
  • 3Poulaki V, Qin W, Joussen AM, et al. Acute insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-indudble factor 1 alpha and VEGF. J Clin Invest, 2002,109:805-815.
  • 4Pore N, Liu S, Shu HK, et al. Spl Is Involved in Akt-mediated Induction of VEGF Expression through an HIF-l-independent Mechanism. Mol Biol Cell,2004, 15: 4841-4853.
  • 5Ferrara N, Gerber HP. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol, 2001,106 : 148-156.
  • 6Chen S, Kasama Y, Lee JS, et al. Podocyte-derived vascular endothelial growth factor mediates the stimulation of a3(1Y) collagen production by transforming growth factor-β1 in mouse podocytes. Diabetes, 2004,53 : 2939-2949.
  • 7Wang G L, Jiang BH, Rue EA,et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proe Natl Aead Sci (USA), 1995,92: 5510-5514.
  • 8Treins C, Giorgetti-Peraldi S, Murdaca J, et al. Insulin stimulates hypoxia-indueible factor 1 through a phosphatidylinositol 3-kinase/target of rapamyein-dependent signaling pathway. J Biol Chem, 2002, 277: 27975-27981.
  • 9Doronzo G, Russo I, MattieUo L, et al. Insulin activates hypoxia-inducible factor-lalpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways., impairment in insulin resistance owing to defects in insulin signalling. Diabetologia, 2006, 49:1049-1063.
  • 10Nangaku M.Hypoxia and tubulointerstitial injury:a final common pathway to end-stage renal failure.Nephron Exp Nephrol,2004,98:e8-e12.

共引文献21

同被引文献52

  • 1邹敏书,何威逊,余健,聂国明.抗Thy-1肾小球肾炎大鼠抗-MIF对TGF-β1表达的影响[J].临床肾脏病杂志,2006,6(6):274-277. 被引量:5
  • 2ltaliani P, Borasthi D. From Monncytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation [ J ]. Front lmmutml, 2014,5:514. Sean Eardley K, Cockwell P. Macrophages and progressive tubu- lninterstitial disease[ J ]. Kidney lnt ,2005,68 ( 2 ) :437 - 55.
  • 3Luo C, Chen M, Madden A, et al. Expression of complement com- tments and regulators by different subtypes of bone marrow - de- rived roach)phages [ J ]. lnflmnmation ,2012,35 (4) : 1448 - 1461.
  • 4Pan B, l,iu G, .liang Z, et d. Regulation of InM tibmsis by mac- rophage polarization[ J ]. Cell Physiol Biochem ,2015,35 ( 3 ) : 1062 - 1069.
  • 5Lichtnekert J, Kawakami T, Parks WC, et al. Changes in macro- phage phenotype as the immune response evolves [ J ]. Curt Opin Pharmaco1,2013,13 (4) :555 - 564.
  • 6Lu J, Cau Q, Zheng D, et al. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in trealing chronic kidney disease[ J ]. Kidney lilt ,2013,84 (4) :745 - 755.
  • 7Ruan CC, Ge Q, Li Y, el al. Complement -mediated macro-phage polarization in perivascular adipose tissue contributes to vas- cular injury in deoxycorticosterone acetate -salt mice[ J ]. Arterio- scler Thrnmb Vase Biol,2015,35 (3) :598 - 606.
  • 8You H, Gao q', Cooper TK, el al. Awad AS. Macrophages direct- ly mediate diabetic renal injury[ J]. Am J Physiol Renal Physinl, 2013,305(12) :1719 - 1727.
  • 9Fujiu K, Manabe 1, Nagai R. Renal collecting duct epithelial cells rebnalate inflammation in tubulointetitial damage in mice [ J ] Ctin lnvest,2011 ,12l(9) :3425 -41.
  • 10Khan SB, Cook HT, Bhaugal G, et al. Pusey CD. Antibody blockade of TNF -'alpha reduces inflammation and scarring in ex- perimental crescentic glomeruhmephritis [ J ]. Kidney lnt,2005, 67(5) :1812 - 1820.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部